enGene Therapeutics Inc.

Biological Products, (No Diagnostic Substances) | SIC: 2836
Phone: (514) 332-4888
CIK: 0001980845
State of Inc.: Z4
Tickers:
  • Nasdaq:ENGN
  • Nasdaq:ENGNW

Form: SCHEDULE 13G/A

Filing Date: 14 May 2026
Report Date:
Accepted: 14 May 2026 08:30 a.m.
Accession Number: 0001373604-26-000042
Act: 34
File Number: 005-94211
Film Number: 26976489

Documents

Primary Document
Accepted: 14 May 2026 08:30 a.m.